Predicted Immunogenicity of CDK12 Biallelic Loss-of-Function Tumors Varies across Cancer Types
- Andrew Elliott
- , Jian Zhang
- , Qing Zhang
- , Jeffrey Swensen
- , Daniel Martin
- , Joanne Xiu
- , Daniel M. Geynisman
- , Daniel Vaena
- , Thomas J. Herzog
- , Robert W. Holloway
- , Wafik S. El-Deiry
- , David Spetzler
- , Elisabeth Heath
- , Phillip Stafford
- , W. Michael Korn
- Caris Life Sciences
- West Cancer Center
- University of Cincinnati
- AdventHealth Cancer Institute
- Brown University
- Wayne State University
- University of California at San Francisco
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations